Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients
Clinical trial NCT02632344 · COMPLETED
Trial details
- NCT number
- NCT02632344
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2022-02-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.